David Ziegler, MD, PhD
David Ziegler is Group Leader of the Brain Tumour Group at Children's Cancer Institute, and Chair of Clinical Trials for the Zero Childhood Cancer personalised medicine program, led by Children's Cancer Institute and Sydney Children's Hospital, Randwick. He holds a conjoint appoint
The Kids Cancer Centre (KCC) at Sydney Children’s Hospital, Randwick (SCH) has been treating children for cancer and blood disorders in NSW, Australia and the Asia-Pacific region for over 50 years. The Early Phase Clinical Trials Centre at the KCC works with scientists, physicians, pharmaceutical companies, and international collaborators to find the most promising results in laboratory research and translate these findings to benefit children with cancer. The primary focus is on children whose disease does not respond to standard therapy, or for whom no effective cure is available. By opening Phase I and Phase II trials, the Centre is able to offer potentially effective new treatments to these children.
Grace Wong | Clinical Research Coordinatorhttps://www.schn.health.nsw.gov.au